09:50  Arrival at the Technopark Campus, near the DiscoPharma building (8952 Schlieren, Wagistrasse 25)

10:00  Visiting DISCO Pharmaceuticals facilities

11:00  Visiting Microcaps facilities

12:00  Lunch together with both company and Technopark representatives.

Please note: the schedule is not final, small changes are still possible. Precise meeting point will be provided closer to the event. 

DISCO Pharmaceuticals is a pre-clinical biotechnology company that leverages its proprietary surfaceome mapping platform to identify novel target pairs on the surface of cancer cells and design surfaceome-targeted bispecific antibody–drug conjugates (ADCs) and T-cell engagers (TCEs) with unprecedented tumor selectivity. 

Microcaps AG is a Swiss startup spun out of ETH Zurich, developing microencapsulation technology for the cosmetic, food, and pharmaceutical industries. Their patented microfluidic platform enables industrial production of size-controlled microcapsules with precise dosing, controlled release, and enhanced stability.